StockData
LABTNasdaqPharmaceutical PreparationsFiscal year ends December 31

Lakewood-Amedex Biotherapeutics Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.58+0.00 (+0.59%)

Close on Oct 19, 2026

Market cap
$828.29K
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Lakewood-Amedex Biotherapeutics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Lakewood-Amedex Biotherapeutics filed with the SEC